Division of Psychiatry, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, Scotland.
Medical Research Council, Human Genetics Unit, University of Edinburgh, Edinburgh, Scotland.
Biol Psychiatry Cogn Neurosci Neuroimaging. 2019 Jan;4(1):91-100. doi: 10.1016/j.bpsc.2018.07.006. Epub 2018 Jul 31.
Major depressive disorder is a clinically heterogeneous psychiatric disorder with a polygenic architecture. Genome-wide association studies have identified a number of risk-associated variants across the genome and have reported growing evidence of NETRIN1 pathway involvement. Stratifying disease risk by genetic variation within the NETRIN1 pathway may provide important routes for identification of disease mechanisms by focusing on a specific process, excluding heterogeneous risk-associated variation in other pathways. Here, we sought to investigate whether major depressive disorder polygenic risk scores derived from the NETRIN1 signaling pathway (NETRIN1-PRSs) and the whole genome, excluding NETRIN1 pathway genes (genomic-PRSs), were associated with white matter microstructure.
We used two diffusion tensor imaging measures, fractional anisotropy (FA) and mean diffusivity (MD), in the most up-to-date UK Biobank neuroimaging data release (FA: n = 6401; MD: n = 6390).
We found significantly lower FA in the superior longitudinal fasciculus (β = -.035, p = .029) and significantly higher MD in a global measure of thalamic radiations (β = .029, p = .021), as well as higher MD in the superior (β = .034, p = .039) and inferior (β = .029, p = .043) longitudinal fasciculus and in the anterior (β = .025, p = .046) and superior (β = .027, p = .043) thalamic radiation associated with NETRIN1-PRS. Genomic-PRS was also associated with lower FA and higher MD in several tracts.
Our findings indicate that variation in the NETRIN1 signaling pathway may confer risk for major depressive disorder through effects on a number of white matter tracts.
重度抑郁症是一种具有多基因结构的临床异质性精神疾病。全基因组关联研究已经在整个基因组中确定了许多与风险相关的变异,并报告了 NETRIN1 途径参与的证据不断增加。通过 NETRIN1 途径内的遗传变异对疾病风险进行分层,可能通过专注于特定过程来提供识别疾病机制的重要途径,排除其他途径中异质的与风险相关的变异。在这里,我们试图研究源自 NETRIN1 信号通路(NETRIN1-PRS)和整个基因组(排除 NETRIN1 途径基因)的重度抑郁症多基因风险评分(genomic-PRS)是否与白质微观结构有关。
我们使用了最新的英国生物银行神经影像学数据发布中的两个扩散张量成像测量值,即各向异性分数(FA)和平均扩散系数(MD)(FA:n=6401;MD:n=6390)。
我们发现,在上纵束(β=-.035,p=.029)中的 FA 显著降低,在丘脑辐射的全局测量中 MD 显著升高(β=.029,p=.021),以及在 superior(β=.034,p=.039)和 inferior(β=.029,p=.043)longitudinal fasciculus 以及 anterior(β=.025,p=.046)和 superior(β=.027,p=.043)thalamic radiation 中 MD 升高与 NETRIN1-PRS 相关。genomic-PRS 也与几个束中的 FA 降低和 MD 升高有关。
我们的研究结果表明,NETRIN1 信号通路的变异可能通过对多个白质束的影响,为重度抑郁症的发生提供风险。